Autolus Therapeutics plc

NasdaqGS:AUTL Stock Report

Market Cap: US$1.1b

Autolus Therapeutics Dividend

Dividend criteria checks 0/6

Autolus Therapeutics does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield2.9%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-US$0.78
Dividend yield forecast in 3Y0%

Recent dividend updates

No updates

Recent updates

We're Hopeful That Autolus Therapeutics (NASDAQ:AUTL) Will Use Its Cash Wisely

Nov 06
We're Hopeful That Autolus Therapeutics (NASDAQ:AUTL) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Autolus Therapeutics' (NASDAQ:AUTL) Cash Burn Situation

Jun 26
Here's Why We're Not Too Worried About Autolus Therapeutics' (NASDAQ:AUTL) Cash Burn Situation

We Think Autolus Therapeutics (NASDAQ:AUTL) Can Afford To Drive Business Growth

Mar 09
We Think Autolus Therapeutics (NASDAQ:AUTL) Can Afford To Drive Business Growth

Is Autolus Therapeutics plc (NASDAQ:AUTL) Worth US$1.9 Based On Its Intrinsic Value?

Dec 12
Is Autolus Therapeutics plc (NASDAQ:AUTL) Worth US$1.9 Based On Its Intrinsic Value?

Autolus stock rises as Moderna uses option to license targeting technology for mRNA therapy

Oct 12

Autolus Therapeutics: Overlooked CAR-T Player With Key Catalysts Approaching

Aug 17

Autolus Therapeutics Q2 2022 Earnings Preview

Aug 03

Here's Why We're Not Too Worried About Autolus Therapeutics' (NASDAQ:AUTL) Cash Burn Situation

Apr 19
Here's Why We're Not Too Worried About Autolus Therapeutics' (NASDAQ:AUTL) Cash Burn Situation

We Think Autolus Therapeutics (NASDAQ:AUTL) Needs To Drive Business Growth Carefully

Dec 15
We Think Autolus Therapeutics (NASDAQ:AUTL) Needs To Drive Business Growth Carefully

Autolus: Developing Better CAR-T In Refractory ALL

Jul 20

Reassessing Autolus Therapeutics

May 04

Will Autolus Therapeutics (NASDAQ:AUTL) Spend Its Cash Wisely?

Apr 28
Will Autolus Therapeutics (NASDAQ:AUTL) Spend Its Cash Wisely?

Do Insiders Own Lots Of Shares In Autolus Therapeutics plc (NASDAQ:AUTL)?

Feb 16
Do Insiders Own Lots Of Shares In Autolus Therapeutics plc (NASDAQ:AUTL)?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if AUTL's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AUTL's dividend payments have been increasing.


Dividend Yield vs Market

Autolus Therapeutics Dividend Yield vs Market
How does AUTL dividend yield compare to the market?
SegmentDividend Yield
Company (AUTL)n/a
Market Bottom 25% (US)1.5%
Market Top 25% (US)4.7%
Industry Average (Biotechs)2.9%
Analyst forecast in 3 Years (AUTL)0%

Notable Dividend: Unable to evaluate AUTL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AUTL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate AUTL's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as AUTL has not reported any payouts.


Discover strong dividend paying companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.